DALLAS – SEPTEMBER 15, 2022 – /OrthoSpineNews/ – The Taiwan Food and Drug Administration (TFDA), part of the Ministry of Health and Welfare, has granted CTL Amedica Company a license for the MATISSE™ Anterior Cervical Interbody Fusion (ACIF) Cage System. The official license, DHA 05603556709, permits CTL Amedica to market the MATISSE™ ACIF Cage System in Taiwan, a vital medical machine market, notably for spinal expertise.
“We’re honored by the TFDA’s approval and are excited to work with our Taiwan distributor associate to make this vital spinal expertise available all through Taiwan,” stated Daniel Chon, CEO of CTL Amedica. “We hope to have it commercially obtainable all through Taiwan within the coming months and finally in markets all through Asia.”
Named after the well-known French impressionist painter Henri Matisse, the MATISSE™ ACIF Cage System is a murals and of science, engineered to accommodate a variety of affected person anatomies and surgeon preferences. It options streamlined instrumentation and a tapered vanguard for straightforward insertion, in addition to, a big graft space to additional promote bone fusion.
The MATISSE™ ACIF Cage System is out there in quite a few footprints, heights, lordotic angles and supplies, together with Titanium, PEEK and Titanium-plated PEEK. Each Titanium and Titanium-plated PEEK characteristic CTL Amedica’s proprietary TiCro™ floor expertise. TiCro™ floor expertise considerably will increase contact floor space and enhances bone interlocking properties.
CTL Amedica is a forward-thinking medical machine design, growth and manufacturing firm. CTL Amedica maintains a Texas-based headquarters and in-house manufacturing facility, together with a Pennsylvania-based R&D Heart of Excellence. A pacesetter within the medical machine expertise and biomaterials house, CTL Amedica offers a full line of cervical, thoracic and lumbar fusion and fixation merchandise. As well as, it’s the world’s unique supplier of silicon nitride spine merchandise. Silicon nitride demonstrates an enhanced osteogenic response for enhanced fusion, promotes distinctive anti-bacterial properties and offers complete imaging throughout all modalities. For extra info, go to https://www.ctlamedica.com/.
Media Contact
Rose Moore Lozelle
CTL Amedica
214-545-5820
RMoore@CTLAmedica.com
SOURCE CTL Amedica
###
Discussion about this post